SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,477,148 | -44.4% | 425,691 | -25.5% | 0.01% | -40.0% |
Q2 2023 | $2,656,977 | -13.5% | 571,393 | -14.0% | 0.02% | -21.1% |
Q1 2023 | $3,070,457 | -43.1% | 664,601 | -0.4% | 0.02% | -47.2% |
Q4 2022 | $5,393,207 | +30.7% | 667,476 | -10.2% | 0.04% | +9.1% |
Q3 2022 | $4,125,000 | -22.2% | 743,228 | -26.9% | 0.03% | -19.5% |
Q2 2022 | $5,299,000 | +3.9% | 1,017,034 | +63.9% | 0.04% | +20.6% |
Q1 2022 | $5,100,000 | +110.2% | 620,480 | +482.2% | 0.03% | +78.9% |
Q1 2021 | $2,426,000 | -29.0% | 106,581 | -32.2% | 0.02% | -36.7% |
Q4 2020 | $3,415,000 | +540.7% | 157,301 | +196.7% | 0.03% | +400.0% |
Q3 2020 | $533,000 | +9.4% | 53,013 | -15.5% | 0.01% | +20.0% |
Q2 2020 | $487,000 | -27.1% | 62,727 | -4.3% | 0.01% | -44.4% |
Q1 2020 | $668,000 | -7.1% | 65,531 | +0.3% | 0.01% | +28.6% |
Q4 2019 | $719,000 | +156.8% | 65,334 | +112.2% | 0.01% | +133.3% |
Q3 2019 | $280,000 | -43.3% | 30,786 | -29.0% | 0.00% | -57.1% |
Q2 2019 | $494,000 | -0.4% | 43,367 | -0.4% | 0.01% | 0.0% |
Q1 2019 | $496,000 | – | 43,526 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
BVF INC/IL | 826,825 | $15,371,000 | 0.58% |